US CELLULAR CORP (USM)
US9116841084 - Common Stock
ChartMill assigns a Buy % Consensus number of 71% to USM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.63. This target is 22.83% above the current price.
USM was analyzed by 11 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about USM.
In the previous month the buy percentage consensus was at a similar level.
USM was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-09 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2023-08-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-07-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-08 | Wells Fargo | Maintains | Underweight |
| 2023-02-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-10 | Wells Fargo | Downgrade | Overweight -> Underweight |
| 2022-11-08 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-11-07 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2022-08-08 | Raymond James | Maintains | Strong Buy |
| 2022-05-09 | Raymond James | Maintains | Strong Buy |
| 2022-04-19 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-02-22 | Wells Fargo | Maintains | Overweight |
| 2022-02-22 | Raymond James | Maintains | Strong Buy |
| 2021-08-02 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-07-22 | Morgan Stanley | Maintains | Overweight |
| 2021-02-22 | JP Morgan | Downgrade | Overweight -> Neutral |